Page results
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page explains what to do if you think your IBD symptoms have returned and who to contact for support.
-
Update about our hospital on Gray's Inn Road
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH is accelerating clinical trial delivery so that patients gain access to new treatments sooner. The acceleration is happening through close collaboration between research teams and clinical services.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
This page is designed to help parents/carers understand the process and what to expect during their child’s admission to the Paediatric ward.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
File results
-
FOI/2021/0643 - Bank and agency staffing vacancy rates and spending
-
FOI/2021/0644 - Clinical guidelines on identification and management of maternity issues
-
FOI/2021/0645 - Software suppliers for various applications
-
FOI/2021/0649 - Physiotherapists/ occupational therapists staffing levels
-
FOI/2021/0650 - Cyber Essentials Accreditation/ Certification
-
FOI/2021/0657 - Patient list for Neuropsychiatry
-
FOI/2021/0653 - Patient Quality Safety Committee in July 2021
-
FOI/2021/0672 - Long Covid statistics
-
FOI/2021/0691 - MHPS investigations
-
FOI/2021/0700 - Treatment of rare diseases